Company profile
Append Medical company profile
Append Medical develops a next-generation transcatheter Left Atrial Appendage (LAA) closure system. The Append Medical solution is in the pre-clinical in-vivo trial phase. It is intended to become a differentiated solution in the LAA closure market, which has been estimated to reach $25B within several years. This is the second-fastest growing segment of the medical device market, with potential sales of $500M in 2019. Append Medical is a member of MEDX Xelerator, a medtech incubator backed by Boston Scientific, Intellectual Ventures, MEDX Ventures and Sheba Medical Center.
Business identity
- Contact email
- [email protected]
- Phone number
- +972-547-250-960
- Operating status
- Active
- Company type
- For Profit
- Employee range
- 00011-00050 employees
- Revenue range
- $1K+
- Founded
- 2015-01-01
Headquarters
- Headquarters
- Or Yehuda, Tel Aviv, Israel
- Postal code
- 6037606
- Country code
- IL
- Continent
- Asia